FBRX·July 27, 2026·activist
Forte Biosciences Agrees to Be Acquired by argenx for $77 Per Share in Cash
Forte Biosciences entered into a definitive merger agreement with argenx BV, which will acquire all outstanding shares of Forte for $77.00 per share in cash through a tender offer and subsequent merger, valuing the transaction at a significant premium.